w/ SOMX ($3.58) I thought the data looked strong as discussed in the conference call from the BIO CEO conference. I am basing my assessment off of that and not what they have historically done since each agent is different as is the data. The trading is definitely bizarre to say the least! If its not appoved then we will know tomorrow as to whether their is legitimacy to this shake out or not.
Message in reply to:
SOMX unlikely to get approval, based on FDAs lack of kindness to sleep medications. See TSPT, and the many before it. Good short from these levels.
News 
Market Data 
Discover 
